IBDEI148 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,18973,2)
 ;;=^5006098
 ;;^UTILITY(U,$J,358.3,18974,0)
 ;;=H46.03^^82^902^22
 ;;^UTILITY(U,$J,358.3,18974,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18974,1,3,0)
 ;;=3^Optic Papillitis,Bilateral
 ;;^UTILITY(U,$J,358.3,18974,1,4,0)
 ;;=4^H46.03
 ;;^UTILITY(U,$J,358.3,18974,2)
 ;;=^5006099
 ;;^UTILITY(U,$J,358.3,18975,0)
 ;;=H46.01^^82^902^24
 ;;^UTILITY(U,$J,358.3,18975,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18975,1,3,0)
 ;;=3^Optic Papillitis,Right Eye
 ;;^UTILITY(U,$J,358.3,18975,1,4,0)
 ;;=4^H46.01
 ;;^UTILITY(U,$J,358.3,18975,2)
 ;;=^5006097
 ;;^UTILITY(U,$J,358.3,18976,0)
 ;;=H46.11^^82^902^30
 ;;^UTILITY(U,$J,358.3,18976,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18976,1,3,0)
 ;;=3^Retrobulbar Neuritis,Right Eye
 ;;^UTILITY(U,$J,358.3,18976,1,4,0)
 ;;=4^H46.11
 ;;^UTILITY(U,$J,358.3,18976,2)
 ;;=^5006101
 ;;^UTILITY(U,$J,358.3,18977,0)
 ;;=H46.12^^82^902^29
 ;;^UTILITY(U,$J,358.3,18977,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18977,1,3,0)
 ;;=3^Retrobulbar Neuritis,Left Eye
 ;;^UTILITY(U,$J,358.3,18977,1,4,0)
 ;;=4^H46.12
 ;;^UTILITY(U,$J,358.3,18977,2)
 ;;=^5006102
 ;;^UTILITY(U,$J,358.3,18978,0)
 ;;=H46.13^^82^902^28
 ;;^UTILITY(U,$J,358.3,18978,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18978,1,3,0)
 ;;=3^Retrobulbar Neuritis,Bilateral
 ;;^UTILITY(U,$J,358.3,18978,1,4,0)
 ;;=4^H46.13
 ;;^UTILITY(U,$J,358.3,18978,2)
 ;;=^5006103
 ;;^UTILITY(U,$J,358.3,18979,0)
 ;;=H47.011^^82^902^16
 ;;^UTILITY(U,$J,358.3,18979,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18979,1,3,0)
 ;;=3^Ischemic Optic Neuropathy,Right Eye
 ;;^UTILITY(U,$J,358.3,18979,1,4,0)
 ;;=4^H47.011
 ;;^UTILITY(U,$J,358.3,18979,2)
 ;;=^5006105
 ;;^UTILITY(U,$J,358.3,18980,0)
 ;;=H47.012^^82^902^15
 ;;^UTILITY(U,$J,358.3,18980,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18980,1,3,0)
 ;;=3^Ischemic Optic Neuropathy,Left Eye
 ;;^UTILITY(U,$J,358.3,18980,1,4,0)
 ;;=4^H47.012
 ;;^UTILITY(U,$J,358.3,18980,2)
 ;;=^5006106
 ;;^UTILITY(U,$J,358.3,18981,0)
 ;;=H47.013^^82^902^14
 ;;^UTILITY(U,$J,358.3,18981,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18981,1,3,0)
 ;;=3^Ischemic Optic Neuropathy,Bilateral
 ;;^UTILITY(U,$J,358.3,18981,1,4,0)
 ;;=4^H47.013
 ;;^UTILITY(U,$J,358.3,18981,2)
 ;;=^5006107
 ;;^UTILITY(U,$J,358.3,18982,0)
 ;;=H20.9^^82^903^14
 ;;^UTILITY(U,$J,358.3,18982,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18982,1,3,0)
 ;;=3^Iridocyclitis,Unspec
 ;;^UTILITY(U,$J,358.3,18982,1,4,0)
 ;;=4^H20.9
 ;;^UTILITY(U,$J,358.3,18982,2)
 ;;=^5005170
 ;;^UTILITY(U,$J,358.3,18983,0)
 ;;=H21.03^^82^903^11
 ;;^UTILITY(U,$J,358.3,18983,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18983,1,3,0)
 ;;=3^Hyphema,Bilateral
 ;;^UTILITY(U,$J,358.3,18983,1,4,0)
 ;;=4^H21.03
 ;;^UTILITY(U,$J,358.3,18983,2)
 ;;=^5005174
 ;;^UTILITY(U,$J,358.3,18984,0)
 ;;=H21.01^^82^903^13
 ;;^UTILITY(U,$J,358.3,18984,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18984,1,3,0)
 ;;=3^Hyphema,Right Eye
 ;;^UTILITY(U,$J,358.3,18984,1,4,0)
 ;;=4^H21.01
 ;;^UTILITY(U,$J,358.3,18984,2)
 ;;=^5005172
 ;;^UTILITY(U,$J,358.3,18985,0)
 ;;=H21.02^^82^903^12
 ;;^UTILITY(U,$J,358.3,18985,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18985,1,3,0)
 ;;=3^Hyphema,Left Eye
 ;;^UTILITY(U,$J,358.3,18985,1,4,0)
 ;;=4^H21.02
 ;;^UTILITY(U,$J,358.3,18985,2)
 ;;=^5005173
 ;;^UTILITY(U,$J,358.3,18986,0)
 ;;=H21.1X2^^82^903^19
 ;;^UTILITY(U,$J,358.3,18986,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18986,1,3,0)
 ;;=3^Vascular Disorders of Iris/Ciliary Body,Left Eye
 ;;^UTILITY(U,$J,358.3,18986,1,4,0)
 ;;=4^H21.1X2
 ;;^UTILITY(U,$J,358.3,18986,2)
 ;;=^5005176
